Mirae Asset Global Etfs Holdings Ltd. Ovid Therapeutics Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Ovid Therapeutics Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 37,012 shares of OVID stock, worth $24,798. This represents 0.0% of its overall portfolio holdings.
Number of Shares
37,012
Previous 35,530
4.17%
Holding current value
$24,798
Previous $33,000
66.67%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding OVID
# of Institutions
85Shares Held
40.1MCall Options Held
1.7KPut Options Held
100-
Rubric Capital Management LP New York, NY5.32MShares$3.56 Million0.05% of portfolio
-
Black Rock Inc. New York, NY3.99MShares$2.67 Million0.0% of portfolio
-
Bvf Inc San Francisco, CA3.85MShares$2.58 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.11MShares$2.08 Million0.0% of portfolio
-
Madison Avenue Partners, LP New York, NY2.47MShares$1.65 Million0.1% of portfolio
About Ovid Therapeutics Inc.
- Ticker OVID
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,419,400
- Market Cap $47.2M
- Description
- Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...